[go: up one dir, main page]

DK2845598T3 - Præparat til anvendelse i forebyggelse og behandling af atypisk osteoporose - Google Patents

Præparat til anvendelse i forebyggelse og behandling af atypisk osteoporose Download PDF

Info

Publication number
DK2845598T3
DK2845598T3 DK12874454.7T DK12874454T DK2845598T3 DK 2845598 T3 DK2845598 T3 DK 2845598T3 DK 12874454 T DK12874454 T DK 12874454T DK 2845598 T3 DK2845598 T3 DK 2845598T3
Authority
DK
Denmark
Prior art keywords
treatment
vitamin
bone
osteoporosis
calcium
Prior art date
Application number
DK12874454.7T
Other languages
English (en)
Inventor
Villorij Ivanovich Strukov
Olga Jhones
Evgenij Nikolaevich Krutiakov
Konstantin Gennad'evich Elistratov
Original Assignee
Obshestvo S Ogranichennoj Otvetstvennostju Parafarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obshestvo S Ogranichennoj Otvetstvennostju Parafarm filed Critical Obshestvo S Ogranichennoj Otvetstvennostju Parafarm
Application granted granted Critical
Publication of DK2845598T3 publication Critical patent/DK2845598T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)

Claims (2)

1. Præparat til forebyggelse eller behandling af atypisk osteoporose med normal eller øget knoglemineralisering af knoglevæv og tilstedeværelsen af hulrum i trabekulære knogledele omfattende drone yngel i en mænge fra 10 mg til 1000 mg og D-vitamin eller vitaminer fra gruppen af D og/eller deres aktive metabolitter i en mængde på 50 IE til 100.000 IE som daglige doser.
2. Præparat til anvendelse ifølge krav 1, kendetegnet ved at præparatet er i form af et pulver, en tablet eller en kapsel.
DK12874454.7T 2012-04-19 2012-08-21 Præparat til anvendelse i forebyggelse og behandling af atypisk osteoporose DK2845598T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012115654/15A RU2497533C1 (ru) 2012-04-19 2012-04-19 Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
PCT/RU2012/000687 WO2013157982A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения атипичного остеопороза

Publications (1)

Publication Number Publication Date
DK2845598T3 true DK2845598T3 (da) 2017-04-10

Family

ID=49383800

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12874454.7T DK2845598T3 (da) 2012-04-19 2012-08-21 Præparat til anvendelse i forebyggelse og behandling af atypisk osteoporose

Country Status (17)

Country Link
US (1) US9827273B2 (da)
EP (1) EP2845598B1 (da)
JP (1) JP6286417B2 (da)
CN (1) CN104736161B (da)
AU (1) AU2012377476B2 (da)
BR (1) BR112014025990B1 (da)
CA (1) CA2870823C (da)
DK (1) DK2845598T3 (da)
EA (1) EA026533B1 (da)
ES (1) ES2616035T3 (da)
IL (1) IL235169B (da)
IN (1) IN2014DN09780A (da)
LT (1) LT2845598T (da)
PL (1) PL2845598T3 (da)
RU (1) RU2497533C1 (da)
UA (1) UA111536C2 (da)
WO (1) WO2013157982A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180249751A1 (en) * 2009-11-30 2018-09-06 Parapharm Llc Preparation for Treating Androgen Deficiency in Women
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
US20190381072A1 (en) * 2012-04-19 2019-12-19 Parapharm Llc Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2577225C1 (ru) * 2015-03-27 2016-03-10 Общество С Ограниченной Ответственностью "Парафарм" Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины
EP4268688A4 (en) * 2021-04-13 2024-09-04 Samsung Electronics Co., Ltd. Cooking apparatus and control method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101684C (zh) * 1997-07-24 2003-02-19 薛大权 蜂蛹钙制剂
AU2004274861A1 (en) * 2003-06-06 2005-03-31 Wyeth Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
JP5509504B2 (ja) * 2008-02-13 2014-06-04 ディーエスエム アイピー アセッツ ビー．ブイ． 骨塩密度を改善し、骨粗鬆症を治療するための２５−ヒドロキシ−ビタミンｄ３とビタミンｄ３の併用
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Also Published As

Publication number Publication date
BR112014025990A2 (pt) 2017-06-27
RU2497533C1 (ru) 2013-11-10
IN2014DN09780A (da) 2015-07-31
AU2012377476A8 (en) 2014-12-18
WO2013157982A1 (ru) 2013-10-24
JP6286417B2 (ja) 2018-02-28
CA2870823A1 (en) 2013-10-24
LT2845598T (lt) 2017-02-27
UA111536C2 (uk) 2016-05-10
EA201401155A1 (ru) 2015-05-29
EA026533B1 (ru) 2017-04-28
CA2870823C (en) 2017-10-03
EP2845598A4 (en) 2015-10-28
CN104736161B (zh) 2021-07-06
JP2015516974A (ja) 2015-06-18
CN104736161A (zh) 2015-06-24
EP2845598A1 (en) 2015-03-11
IL235169A0 (en) 2014-12-31
PL2845598T3 (pl) 2017-07-31
US9827273B2 (en) 2017-11-28
US20150224150A1 (en) 2015-08-13
IL235169B (en) 2019-10-31
BR112014025990B1 (pt) 2021-02-17
AU2012377476B2 (en) 2017-10-05
EP2845598B1 (en) 2017-01-04
ES2616035T3 (es) 2017-06-09
AU2012377476A1 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
DK2845598T3 (da) Præparat til anvendelse i forebyggelse og behandling af atypisk osteoporose
JP2015516974A5 (ja) 骨の線維柱帯における空洞病巣発生を有する正常又は増加した骨組織石灰化に伴う非定型骨粗鬆症を対象にする予防または治療剤
AU2017203767B2 (en) Method for filling bone cavity formations with calcium
AU2012377478B2 (en) Preparation and method for the prophylaxis and treatment of osteoporosis and bone fractures
IL265571A (en) Preparations and methods for the treatment of orthopedic diseases
BR112017007364B1 (pt) Composições farmacêuticas e usos das mesmas para o tratamento ou prevenção de deficiências de vitaminas e minerais em pacientes submetidos à cirurgia de bypass gástrico
US20190381072A1 (en) Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
Sadeghi et al. Effect of Regular Resistance Exercise, Vitamin D and Calcium Supplements in Pre-menopausal Period on the Bone Mineral Density in Rats
NZ619215B2 (en) Method for filling bone cavities with calcium
Bačun et al. VITAMIN D SUPPLEMENTATION IN ELDERLY PEOPLE WITH OSTEOPOROSIS, OSTEOPENIA AND OSTEOSARCOPENIA
Cardoso et al. Transtrochanterian fractures: postoperative use of alendronate